Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dibromodulcitol plus BCNU in supratentorial malignant brain gliomas
NCT00002620Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Nov 1994
- Primary completion
- Jun 2000
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised trial of mitolactol and carmustine in anaplastic astrocytoma (AA) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoints: Disease-Free Interval and Survival. Started Nov 1994; status: completed.
02
Drugs
mitolactolcarmustine
03
Conditions
anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT00002620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002620.